{"Name":"Tercica","perma":"tercica","BasicInfo":{"funded":"2002-01-01","isClosed":false,"closed":null,"short":"Tercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases."},"FundingRounds":[{"funding_type":"private_equity","series":null,"announcedDate":"2007-07-06","moneyRaised":8000000},{"funding_type":"private_equity","series":null,"announcedDate":"2005-10-14","moneyRaised":75000000},{"funding_type":"venture","series":"B","announcedDate":"2003-07-18","moneyRaised":44000000},{"funding_type":"venture","series":"A","announcedDate":"2002-03-27","moneyRaised":21500000}],"Acquisitions":[],"AcquiredBy":{"price":373000000,"paymentType":null,"announcedDate":"2008-06-04","completedDate":"2008-10-21","acquisitionType":"Acquisition","acquirer":"Ipsen"},"IPO":{"exchange":"NASDAQ","symbol":"TRCA","shares":6000000,"date":"2004-03-17","openPrice":9,"moneyRaised":49500000,"valuation":null},"Investments":[],"Products":[],"CurrentTeam":[{"title":"President and COO","started":null,"ended":null,"firstName":"Richard","lastName":"King"},{"title":"CEO","started":null,"ended":null,"firstName":"John","lastName":"A. Scarlett"},{"title":"CEO","started":null,"ended":null,"firstName":"Cynthia","lastName":"Schwalm"}],"PastTeam":[{"title":"Senior Vice President and Chief Medical Officer","started":"2005-01-01","ended":"2009-01-01","firstName":"Thorsten","lastName":"von Stein"},{"title":"CFO and EVP","started":null,"ended":null,"firstName":"Ajay","lastName":"Bansal"},{"title":"Vice President of Marketing","started":"2007-01-01","ended":"2008-12-01","firstName":"Russell","lastName":"Cox"},{"title":"President & Chief Operating Officer","started":"2007-02-01","ended":"2009-06-01","firstName":"Richard","lastName":"King"}]}
